Stocktoria
CELESTICA INC CLS
CELESTICA INC financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $12.4B | $9.6B | $8.0B |
| Gross profit | $1.5B | $1.0B | $754.1M |
| R&D expense | $118.2M | $78.0M | $60.9M |
| SG&A expense | $259.9M | $293.5M | $303.2M |
| Operating income | $1.0B | $599.3M | $338.3M |
| Income tax | $150.7M | $104.2M | $61.6M |
| Net income | $832.5M | $428.0M | $244.4M |
| EPS (diluted) | $7.16 | $3.61 | $2.03 |
| Operating cash flow | $659.5M | $473.9M | $326.2M |
| Cash & equivalents | $595.6M | $423.3M | $370.4M |
| Inventory | $2.2B | $1.8B | $2.1B |
| Total assets | $7.2B | $6.0B | $5.9B |
| Total liabilities | $5.0B | $4.1B | $4.1B |
| Shareholders' equity | $2.2B | $1.9B | $1.8B |
Growth · year-over-year · Revenue CAGR 24.8%
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue growth | +28.5% | +21.2% | — |
| Net income growth | +94.5% | +75.1% | — |
| EPS growth | +98.3% | +77.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.